Neowise
About:
XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.
Website: https://www.neowisebio.com/
Top Investors: Oriza Holdings, Marathon Venture Partners, TF Capital, Zhongxin Capital, Shanghai Zhangjiang Leading Qifan Venture Capital
Description:
Total Funding Amount:
200M CNY
Headquarters Location:
Suzhou, Jiangsu, China
Founded Date:
2020-09-28
Contact Email:
info(AT)neowisebio.com
Founders:
Number of Employees:
51-100
Last Funding Date:
2023-03-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai